Effects of treatment of COVID-19 with convalescent plasma in 25 B-cell depleted patients.

Arvind Gharbharan,Corine H. GeurtsvanKessel,Carlijn C E Jordans,Marc Blaauw,Marjolein van der Klift,Robert-Jan Hassing,Marijn Smits-Zwinkels,Maaike Meertens,Ella C van den Hout,Anne Marie de Man, Ilse M.G. Hageman,Susanne Bogers,C. Ellen van der Schoot,Francis Swaneveld,Adam A Anas,Casper Rokx,Bart J. A. Rijnders

Clinical Infectious Diseases（2021）

引用 18|浏览11

暂无评分

摘要

25 B-cell depleted patients (24 following anti-CD19/20 therapy) diagnosed with COVID-19, had been symptomatic for a median of 26 days but remained antibody negative. All were treated with convalescent plasma with high neutralizing antibody titers. 21 (84%) recovered, indicating the potential therapeutic effects of this therapy in this particular population.

查看译文

关键词

coronavirus disease,convalescent plasma,b-cell

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要